LP
AGN

LGL Partners’s Allergan plc AGN Stock Holding History

LGL Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,360
Closed -$331K – 92
2017
Q2 		$331K Sell
1,360
-8
-0.6% -$1.88K 0.18% 64
2017
Q1 		$327K Hold
1,368
– – 0.17% 67
2016
Q4 		$287K Sell
1,368
-1,076
-44% -$223K 0.16% 77
2016
Q3 		$569K Sell
2,444
-50
-2% -$12.2K 0.3% 39
2016
Q2 		$594K Hold
2,494
– – 0.32% 38
2016
Q1 		$668K Hold
2,494
– – 0.34% 40
2015
Q4 		$779K Buy
+2,494
New +$743K 0.42% 37

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

LGL Partners's AGN Position: Q3 2017 in Review

LGL Partners sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 1,360 shares — an estimated $331K sold.

LGL Partners first reported a position in AGN in Q4 2015 and held it in 7 quarters. The position peaked at $779K in Q4 2015. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

  • LGL Partners reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
  • LGL Partners sold 1,360 Allergan plc shares in Q3 2017, an estimated $331K.
  • LGL Partners first reported a position in Allergan plc in Q4 2015 and held it in 7 quarters.
  • LGL Partners's Allergan plc position peaked at $779K in Q4 2015.
  • 1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on LGL Partners's 13F filing for Q3 2017, filed 14 Nov 2017.